ryan braun wide getty

In focusing on Braun, Major League Baseball is abandoning the principles of its drug testing/enforcement program


Been doing some more thinking about the story this morning about how Major League Baseball is laser-focused on Ryan Braun in the Biogenesis investigation, to the point where it is considering giving players immunity in an effort to nab him and some of the bigger fish.

As a basic premise, I don’t have a real problem with that. This is how police work is usually done: get the small fish to flip on the big fish and so forth. I think this differs from the organized crime analogy in that here the “big fish” is only one player whose violation is no different in kind or magnitude than that of any other person cheating — and, as such, going after Braun like this is likely to cause MLB to overlook multiple more cheaters who collectively represent a greater ill to baseball than one more famous cheater — but that’s their prerogative. If they get the goods on Braun and punish him, fine, he’s punished.

All of that said, in pursuing things in such a way it’s inescapable that Major League Baseball is abandoning some of the core principles of the drug program as currently constructed.

For one thing: zero tolerance. The most adamant anti-PED folks on the planet, including WADA and USADA have spent decades telling us that zero tolerance is critical to any drug testing regime and that only through zero tolerance can you have a level competitive landscape. In singling out Braun, however, and standing willing to grant immunity to some players in order to get him, Major League Baseball is abandoning that principle. It is saying that some cheaters are more important than others. Which is the same as saying that some cheating will, in effect, be tolerated and will go unpunished.

And maybe Major League Baseball is fine with that. If so, they should say so. And if so they should cease selectively applying the standards of zero tolerance. I mean, if MLB is satisfied that it can weigh the words and determine the truthfulness of one player’s word over another’s and that it can mete out differential enforcement like this and not harm the very essence of the Joint Drug Agreement, surely it can listen to defenses of inadvertent contamination and accidental ingestion of various stimulants and PEDs, can it not? Now Bud Selig says that it can’t do that for risk of imperiling zero tolerance principles. But if the Biogenesis investigation throws such principles over the side, what is left to protect?

Also being abandoned right now: the anonymity of the testing and enforcement process.  Major League Baseball’s fixation on Braun is of such a high pitch, it appears, that it was deemed unique and newsworthy by someone privy to the process and thus was leaked to Bob Nightengale of USA Today. Since when is that acceptable? The last time news of a drug investigation/enforcement proceeding was made public it led to MLB being publicly embarrassed when that outfielder from Milwaukee beat the rap. How did that turn out for you, Mr. Selig? And how has it turned out for that outfielder, whose name will always be mud to some folks regardless of what the future holds?

If Ryan Braun cheated — and if Major League Baseball can prove it — yes, he should absolutely be punished. And at this point, if what Nightengale is reporting is true, I’d lay better odds on Braun getting popped than him getting off.  But in getting that head on a platter it’s inescapable that Major League Baseball is transforming its drug testing and enforcement regime from a clinically-based program into a police operation.  And in doing so, it appears willing to abandon zero tolerance, anonymity, uniform enforcement and everything the league tells us is so good about the Joint Drug Agreement in the first place.

Hope it’s worth it, guys.

Kyle Schwarber is on a private plane en route to Cleveland

PHOENIX, AZ - APRIL 07:  Kyle Schwarber #12 of the Chicago Cubs bats against the Arizona Diamondbacks during the MLB game at Chase Field on April 7, 2016 in Phoenix, Arizona.  (Photo by Christian Petersen/Getty Images)
Getty Images

This is happening, people.

Earlier we heard Joe Maddon being non-committal about Kyle Schwarber joining the Cubs for the World Series. Now it seems pretty clear that the Cubs are committal indeed: Jon Morosi reports that Schwarber is en route to Cleveland from Arizona on a private jet and that he’s expected to DH in Game 1 tomorrow night.

Schwarber hasn’t played in a game that counted since April 7. His potent bat is could be a windfall for a Cubs team that didn’t have a game-changing option at DH in the American League park.

Schwarber lost the whole season due to a knee injury, but he hit .246/.355/.487 with 16 homers and 43 RBI in 69 games as a rookie in 2015. His big coming out party was in the playoffs, however, when he hit three homers in five postseason games while going 7-for-13 with two walks in five games.

Carlos Santana in left field? Sure, OK.

CLEVELAND, OH - OCTOBER 15:  Carlos Santana #41 of the Cleveland Indians celebrates after hitting a home run in the second inning against J.A. Happ #33 of the Toronto Blue Jays during game two of the American League Championship Series at Progressive Field on October 15, 2016 in Cleveland, Ohio.  (Photo by Maddie Meyer/Getty Images)
Getty Images

Paul Hoynes of the Cleveland Plain Dealer reports that Indians First Baseman/DH Carlos Santana shagged some flyballs in left field during the Indians’ workout today.

Sure, why not? Santana has played one game in the outfield in his major league career and that was over four years ago, but the Indians will have to play in Chicago without the DH, meaning either losing Santana’s bat or that of Mike Napoli.

It would be up to Terry Francona to decide if that happens, but ultimately I don’t think he’ll make it real and, rather, will just forget about it, because Santana’s defense out there would in no way be smooth.

I’m sorry. I’m sick today and I’m on a lot of cold medicine.